Skip to main content
Research project

CTU - CCTG- Crabb - A RANDOMIZED PHASE II TRIAL ASSESSING TRIMODALITY THERAPY WITH OR WITHOUT ADJUVANT DURVALUMAB TO TREAT PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER

Research groups:
Lead researcher:
Other researchers:
Research funder:
Queen's University at Kingston
Status:
Active
Back to top